Patents by Inventor Sylvian Chemtob

Sylvian Chemtob has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CCR2 antagonist peptides
    Patent number: 10253087
    Abstract: The invention relates to a peptide useful as a CCR2 non-competitive antagonist peptide.
    Type: Grant
    Filed: May 1, 2018
    Date of Patent: April 9, 2019
    Assignee: Sorbonne University
    Inventors: Christophe Combadiere, Florian Sennlaub, Constance Auvynet, Sylvian Chemtob, Christiane Quiniou
  • CCR2 ANTAGONIST PEPTIDES
    Publication number: 20180251523
    Abstract: The invention relates to a peptide comprising the following amino acid sequence useful as a CCR2 non competitive antagonist peptide.
    Type: Application
    Filed: May 1, 2018
    Publication date: September 6, 2018
    Applicant: UNIVERSITE PIERRE ET MARIE CURIE (Paris 6)
    Inventors: Christophe Combadiere, Florian Sennlaub, Constance Auvynet, Sylvian Chemtob, Christiane Quiniou
  • CCR2 antagonist peptides
    Patent number: 9434766
    Abstract: The invention relates to a peptide comprising the following amino acid sequence Thr-Phe-Leu-Lys (SEQ ID NO: 17) or Thr-Phe-Leu-Lys-Cys (SEQ ID NO: 1), useful as a CCR2 non-competitive antagonist peptide.
    Type: Grant
    Filed: June 26, 2012
    Date of Patent: September 6, 2016
    Assignee: Universite Pierre Et Marie Curie (Paris 6)
    Inventors: Christophe Combadiere, Florian Sennlaub, Constance Auvynet, Sylvian Chemtob, Christiane Quiniou